+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase binding sites on human foreskin cells. Evidence for occupancy with endogenous urokinase



Urokinase binding sites on human foreskin cells. Evidence for occupancy with endogenous urokinase



Biochemical and Biophysical Research Communications 133(3): 994-1000



In cultures of human foreskin fibroblasts most of the cell surface binding sites for 2-chain urokinase are masked and can be exposed by 10 min. incubation on ice at pH 2.5 (A. Bajpai and J.B. Baker (1985), Biochem. Biophys. Res. Commun.133, 475-482). Here we show that incubation on ice at pH 2.5 also releases from the cell surface a plasminogen activator that is similar to 2-chain urokinase in terms of its electrophoretic mobility, chromatographic behavior on concanavalin A-Sepharose or p-amino-benzamidine-Sepharose, and sensitivity to anti-urokinase antibody. Two observations suggest that the masked binding sites are sites occupied by this cell surface urokinase. First, glucocorticoid-treated cells, which lack cell surface urokinase, have a large number of urokinase binding sites but none that are masked. Second, the extraction of surface urokinase and the exposure of urokinase binding sites exhibit similar pH dependence. Both are complete at about pH 4.0.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041910897

Download citation: RISBibTeXText

PMID: 3002380

DOI: 10.1016/0006-291x(85)91234-3


Related references

Cryptic urokinase binding sites on human foreskin fibroblasts. Biochemical and Biophysical Research Communications 133(2): 475-482, 1985

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. Journal of Biological Chemistry 269(41): 25668-25676, 1994

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic a2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. The Journal of Biological Chemistry 269: 668-76, 1994

Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex. Journal of Biological Chemistry 261(3): 1267-1273, 1986

Post-transcriptional regulation of urokinase mRNA. Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro. Journal of Biological Chemistry 275(18): 13771-9, 2000

Invasion by esophageal cancer cells: Functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor. Clinical and Experimental Metastasis 17(1): 77-85, 1999

Single chain and two chain urokinase but not low molecular weight urokinase possess high affinity binding sites for zinc ii. Fibrinolysis 4(Suppl. 3): 26, 1990

Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor. Journal of Biological Chemistry 273(50): 33267-33272, 1998

Fibrin-binding urokinase (or precursor form of urokinase) with a molecular weight of about 100,000 in fresh human urine. Enzyme 34(4): 201-211, 1985

Disruption of Rel binding sites in the human urokinase promoter results in its significantly decreased transcriptional activity in human ovarian carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 38: 411, 1997

Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 81(12): 3285-3292, 1993

Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Molecular and Cellular Biology 17(3): 1075-1083, 1997

Differential binding of urokinase and peptide antagonists to the urokinase receptor: evidence from characterization of the receptor in four primate species. Biological Chemistry 382(3): 435-442, 2001

Spontaneous clot lysis in whole human plasma by endogenous tissue type and urokinase type plasminogen activators demonstration of a promoting effect by t pa and by platelets on urokinase. Fibrinolysis 2(3): 143-150, 1988